January 2, 2025 — Will savings from reduced food and beverage spending be sufficient to cover the cost of obesity medicines? Will these medicines transform the patterns of a whole range of consumer purchases? Speculation about GLP-1s, consumers, and economics is rampant right now. It’s popping up in both serious economic reporting and academic journals. The speculation is only […]
October 16, 2024 — Jabs for jobs. This very British headline sums up a bold effort in the UK to assess the economics of providing better access to obesity care within the National Health System. Right now, access to obesity care is highly constrained, reflecting an outdated presumption within the NHS that “we cannot treat our way out of […]
July 19, 2024 — “If we were just to get a fraction [of potential members] to engage in the way that we do things differently with GLP-1s – it’s an insane opportunity for the company.” These words come from the Life Time chain of fitness clubs about the “Miora” wellness clinics they are now putting inside their facilities. It […]
July 12, 2019 — Late yesterday, we received a jolt of good news. The Supreme Court for the State of Washington ruled that employers cannot discriminate against qualified job candidates on account of obesity. That’s right. We now have one more state where job discrimination on account of obesity is illegal. Job Offer Revoked Because of Six Pounds Twelve […]
